SK Bioscience Co.,Ltd Logo

SK Bioscience Co.,Ltd

A biopharma firm developing and manufacturing vaccines and offering CDMO services.

302440 | KO

Overview

Corporate Details

ISIN(s):
KR7302440003
LEI:
Country:
South Korea
Address:
경기도 성남시 분당구 판교로 310, 성남시

Description

SK Bioscience is a biopharmaceutical company focused on the research, development, manufacturing, and commercialization of vaccines and biological products. Spun off from SK Chemicals in 2018, the company develops its own pipeline of vaccines, including cell-culture-based influenza vaccines and a COVID-19 vaccine, utilizing its established R&D and production platforms. In addition to its proprietary products, SK Bioscience provides global Contract Development and Manufacturing Organization (CDMO) services, offering end-to-end support from process development to large-scale commercial manufacturing for international partners. The company is dedicated to promoting public health by providing innovative preventative solutions to address global health challenges.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2026-01-06 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean HTML 24.6 KB
2026-01-06 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean HTML 24.5 KB
2025-12-29 00:00
[기재정정]신규시설투자등
Korean HTML 12.9 KB
2025-12-26 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean HTML 24.6 KB
2025-12-26 00:00
최대주주등소유주식변동신고서
Korean HTML 25.0 KB
2025-12-23 00:00
[기재정정]단일판매ㆍ공급계약체결
Korean HTML 14.5 KB
2025-09-19 00:00
임원ㆍ주요주주특정증권등거래계획보고서
Korean HTML 47.1 KB
2025-09-19 00:00
특수관계인에대한부동산매도
Korean HTML 5.2 KB
2025-09-19 00:00
주식등의대량보유상황보고서(일반)
Korean HTML 92.4 KB
2025-08-29 00:00
대규모기업집단현황공시[분기별공시(개별회사용)]
Korean HTML 7.9 KB
2025-08-13 00:00
지급수단별ㆍ지급기간별지급금액및분쟁조정기구에관한사항
Korean HTML 11.0 KB
2025-08-12 00:00
반기보고서 (2025.06)
Korean HTML 4.3 MB
2025-07-31 00:00
연결재무제표기준영업(잠정)실적(공정공시)
Korean HTML 15.0 KB
2025-07-31 00:00
기업설명회(IR)개최(안내공시)
Korean HTML 6.1 KB
2025-07-21 00:00
기업설명회(IR)개최(안내공시)
Korean HTML 6.1 KB

Automate Your Workflow. Get a real-time feed of all SK Bioscience Co.,Ltd filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for SK Bioscience Co.,Ltd

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for SK Bioscience Co.,Ltd via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Access Bio, Inc. Logo
Develops and manufactures in vitro diagnostic solutions for infectious diseases.
United States of America
950130
ACHIEVE LIFE SCIENCES, INC. Logo
A late-stage pharmaceutical company developing a treatment for nicotine dependence.
United States of America
ACHV
AC Immune SA Logo
Biopharmaceutical firm developing precision medicine for neurodegenerative diseases.
United States of America
ACIU
Aclaris Therapeutics, Inc. Logo
Clinical-stage biopharmaceutical company developing drugs for immuno-inflammatory diseases.
United States of America
ACRS
Acrivon Therapeutics, Inc. Logo
Clinical-stage biopharma using proteomics to develop precision oncology therapies.
United States of America
ACRV
Acticor Biotech Logo
Develops treatments for thrombotic diseases, focusing on acute ischemic stroke.
France
ALACT
Actinium Pharmaceuticals, Inc. Logo
Clinical-stage company developing targeted radiotherapies for difficult-to-treat cancers.
United States of America
ATNM
ACTUATE THERAPEUTICS, INC. Logo
Clinical-stage biopharma developing therapies for cancers with high unmet needs.
United States of America
ACTU
AcuCort AB Logo
Develops user-friendly drug formulations for severe and acute allergic reactions.
Sweden
ACUC
Acumen Pharmaceuticals, Inc. Logo
Clinical-stage biopharma developing targeted therapies for Alzheimer's disease.
United States of America
ABOS

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.